|
1
|
Scarano MI, Strazzullo M, Matarazzo MR and
D’Esposito M: DNA methylation 40 years later: Its role in human
health and disease. J Cell Physiol. 204:21–35. 2005.PubMed/NCBI
|
|
2
|
Jones PA and Baylin SB: The fundamental
role of epigenetic events in cancer. Nat Rev Genet. 3:415–428.
2002.PubMed/NCBI
|
|
3
|
Esteller M: Epigenetics in cancer. N Engl
J Med. 358:1148–1159. 2008. View Article : Google Scholar
|
|
4
|
Pfister S, Schlaeger C, Mendrzyk F, et al:
Array-based profiling of reference-independent methylation status
(aprimes) identifies frequent promoter methylation and consecutive
downregulation of zic2 in pediatric medulloblastoma. Nucleic Acids
Res. 35:e512007. View Article : Google Scholar
|
|
5
|
Huang TH, Perry MR and Laux DE:
Methylation profiling of cpg islands in human breast cancer cells.
Hum Mol Genet. 8:459–470. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yan PS, Potter D, Deatherage DE, Huang TH
and Lin S: Differential methylation hybridization: profiling DNA
methylation with a high-density cpg island microarray. Methods Mol
Biol. 507:89–106. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Herath NI, Leggett BA and MacDonald GA:
Review of genetic and epigenetic alterations in
hepatocarcinogenesis. J Gastroenterol Hepatol. 21:15–21. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Park IY, Sohn BH, Yu E, Suh DJ, Chung YH,
Lee JH and Surzycki SJ: Aberrant epigenetic modifications in
hepatocarcinogenesis induced by hepatitis B virus X protein.
Gastroenterology. 132:1476–1494. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang L, Wang WL, Zhang Y, Guo SP, Zhang J
and Li QL: Epigenetic and genetic alterations of pten in
hepatocellular carcinoma. Hepatol Res. 37:389–396. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Calvisi DF, Ladu S, Gorden A, et al:
Mechanistic and prognostic significance of aberrant methylation in
the molecular pathogenesis of human hepatocellular carcinoma. J
Clin Invest. 117:2713–2722. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Calvisi DF, Ladu S, Gorden A, et al:
Molecular pathogenesis of human hepatocellular carcinoma:
Mechanistic and prognostic significance of aberrant methylation.
AACR Meeting Abstracts. 2006:763a2006.
|
|
12
|
Thorgeirsson SS and Grisham JW: Molecular
pathogenesis of human hepatocellular carcinoma. Nat Genet.
31:339–346. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pei Y, Zhang T, Renault V and Zhang X: An
overview of hepatocellular carcinoma study by omics-based methods.
Acta Biochim Biophys Sin. 41:1–15. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Frommer M, McDonald LE, Millar DS, et al:
A genomic sequencing protocol that yields a positive display of
5-methylcytosine residues in individual DNA strands. Proc Natl Acad
Sci USA. 89:1827–1831. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Humeniuk R, Mishra PJ, Bertino JR and
Banerjee D: Molecular targets for epigenetic therapy of cancer.
Curr Pharm Biotechnol. 10:161–165. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schneider-Stock R and Ocker M: Epigenetic
therapy in cancer: Molecular background and clinical development of
histone deacetylase and DNA methyltransferase inhibitors. IDrugs.
10:557–561. 2007.
|
|
17
|
Issa JP: Cpg island methylator phenotype
in cancer. Nat Rev Cancer. 4:988–993. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shen L, Catalano PJ, Benson AB III,
O’Dwyer P, Hamilton SR and Issa JP: Association between DNA
methylation and shortened survival in patients with advanced
colorectal cancer treated with 5-fluorouracil-based chemotherapy.
Clin Cancer Res. 13:6093–6098. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tommasi S, Pinto R, Pilato B and Paradiso
A: Molecular pathways and related target therapies in liver
carcinoma. Curr Pharm Des. 13:3279–3287. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pang RW and Poon RT: From molecular
biology to targeted therapies for hepatocellular carcinoma: the
future is now. Oncology. 72(Suppl 1): 30–44. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gollob JA, Wilhelm S, Carter C and Kelley
SL: Role of Raf kinase in cancer: therapeutic potential of
targeting the Raf/mek/erk signal transduction pathway. Semin Oncol.
33:392–406. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Prasad CP, Mirza S, Sharma G, et al:
Epigenetic alterations of cdh1 and apc genes: relationship with
activation of wnt/beta-catenin pathway in invasive ductal carcinoma
of breast. Life Sci. 83:318–325. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Banno K, Yanokura M, Susumu N, et al:
Relationship of the aberrant DNA hypermethylation of cancer-related
genes with carcinogenesis of endometrial cancer. Oncol Rep.
16:1189–1196. 2006.PubMed/NCBI
|
|
24
|
Supic G, Kozomara R, Brankovic-Magic M,
Jovic N and Magic Z: Gene hypermethylation in tumor tissue of
advanced oral squamous cell carcinoma patients. Oral Oncol.
45:1051–1057. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kumar SR, Singh J, Xia G, et al: Receptor
tyrosine kinase ephb4 is a survival factor in breast cancer. Am J
Pathol. 169:279–293. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Noren NK, Lu M, Freeman AL, Koolpe M and
Pasquale EB: Interplay between ephb4 on tumor cells and vascular
ephrin-b2 regulates tumor growth. Proc Natl Acad Sci USA.
101:5583–5588. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Berclaz G, Karamitopoulou E, Mazzucchelli
L, et al: Activation of the receptor protein tyrosine kinase ephb4
in endometrial hyperplasia and endometrial carcinoma. Ann Oncol.
14:220–226. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bashaw GJ and Goodman CS: Chimeric axon
guidance receptors: the cytoplasmic domains of slit and netrin
receptors specify attraction versus repulsion. Cell. 97:917–926.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Stella MC, Trusolino L and Comoglio PM:
The slit/robo system suppresses hepatocyte growth factor-dependent
invasion and morphogenesis. Mol Biol Cell. 20:642–657. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu ZJ and Herlyn M: Slit-Robo: neuronal
guides signal in tumor angiogenesis. Cancer Cell. 4:1–2. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Marlow R, Strickland P, Lee JS, et al:
Slits suppress tumor growth in vivo by silencing sdf1/cxcr4 within
breast epithelium. Cancer Res. 68:7819–7827. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang B, Xiao Y, Ding BB, et al: Induction
of tumor angiogenesis by slit-robo signaling and inhibition of
cancer growth by blocking robo activity. Cancer Cell. 4:19–29.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hohenester E: Structural insight into
slit-robo signalling. Biochem Soc Trans. 36:251–256. 2008.
View Article : Google Scholar : PubMed/NCBI
|
